Eli Lilly Flips Teva 'Free Ride' Claim As Migraine Trial Wraps
By Brian Dowling · November 8, 2022, 2:58 PM EST
Three weeks after Teva Pharmaceuticals opened a patent infringement suit by accusing Eli Lilly and Co. of free riding on intellectual property undergirding its migraine drug, Lilly told the jury Tuesday...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login